Your Article Summary
Human genome sciences invites investors to listen to webcast of presentation at analyst & investor meeting
Human Genome Sciences, 10/15/09
Human Genome Sciences, Inc. announced that its senior management will discuss BENLYSTA and the Phase 3 BLISS–52 trial results during an Analyst & Investor Meeting the Company will host at the 2009 American College of Rheumatology Annual Scientific Meeting.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09
User Groups Prove Helpful
HealthDataManagement, 11/03/09
Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09
Article Search
Sponsor


See Latest Articles


